1 | pressures | 4,092 |
2 | stasis | 964 |
3 | gases | 743 |
4 | pressure-lowering | 265 |
5 | clots | 131 |
6 | rheology | 105 |
7 | pressure-independent | 40 |
8 | pressure-related | 21 |
9 | pressure/diastolic | 16 |
10 | airflows | 15 |
11 | pwvs | 12 |
12 | gasses | 11 |
13 | phobics | 10 |
14 | pressure-reducing | 10 |
15 | pressure-guided | 7 |
16 | pressure/mean | 7 |
17 | stasis-phlegm | 7 |
18 | parcels | 6 |
19 | cell-perfused | 5 |
20 | stasis-heat | 5 |
21 | circulation-invigorating | 3 |
22 | circulation-related | 3 |
23 | drags | 3 |
24 | flow/systemic | 3 |
25 | stasis-type | 3 |
26 | tinged | 3 |
27 | wave/em | 3 |
28 | bankers | 2 |
29 | bmc/bw | 2 |
30 | cd16/56 | 2 |
31 | mdt-15 | 2 |
32 | pressure-a | 2 |
33 | pressure-insulin | 2 |
34 | pressure-regulating | 2 |
35 | pressure≥140 | 2 |
36 | stasis-dredging | 2 |
37 | time/rr | 2 |
38 | cell-alloimmunized | 1 |
39 | cell-neutrophil | 1 |
40 | cell-transfused | 1 |
41 | cell/red | 1 |
42 | convection-parameterized | 1 |
43 | detoxification/purification | 1 |
44 | donors.we | 1 |
45 | flow/mean | 1 |
46 | flow/metabolism | 1 |
47 | incoagulability | 1 |
48 | institute-limited | 1 |
49 | karyocytes | 1 |
50 | leucocyte-mainly | 1 |
51 | leukocytes.clinicaltrials.gov | 1 |
52 | loss-and | 1 |
53 | middle/low | 1 |
54 | mvgs | 1 |
55 | nondippings | 1 |
56 | outdating | 1 |
57 | postadsorber | 1 |
58 | pressure-by | 1 |
59 | pressure-loweringtherapies | 1 |
60 | pressure.further | 1 |
61 | pressurematched | 1 |
62 | pressures≥30mmhg | 1 |
63 | pressure≥90 | 1 |
64 | products/24 | 1 |
65 | proteins/steroids | 1 |
66 | prssure | 1 |
67 | samples/dna | 1 |
68 | schizontocides | 1 |
69 | slides/month | 1 |
70 | smear-confirmed | 1 |
71 | stasis/stagnant | 1 |
72 | sugar-reducing | 1 |
73 | technology® | 1 |
74 | time/blood | 1 |
75 | transfusion-and | 1 |
76 | transfusion/iron | 1 |
77 | velocity/end-diastolic | 1 |
1 | airflows | 15 |
2 | bankers | 2 |
3 | bmc/bw | 2 |
4 | cd16/56 | 2 |
5 | cell-alloimmunized | 1 |
6 | cell-neutrophil | 1 |
7 | cell-perfused | 5 |
8 | cell-transfused | 1 |
9 | cell/red | 1 |
10 | circulation-invigorating | 3 |
11 | circulation-related | 3 |
12 | clots | 131 |
13 | convection-parameterized | 1 |
14 | detoxification/purification | 1 |
15 | donors.we | 1 |
16 | drags | 3 |
17 | flow/mean | 1 |
18 | flow/metabolism | 1 |
19 | flow/systemic | 3 |
20 | gases | 743 |
21 | gasses | 11 |
22 | incoagulability | 1 |
23 | institute-limited | 1 |
24 | karyocytes | 1 |
25 | leucocyte-mainly | 1 |
26 | leukocytes.clinicaltrials.gov | 1 |
27 | loss-and | 1 |
28 | mdt-15 | 2 |
29 | middle/low | 1 |
30 | mvgs | 1 |
31 | nondippings | 1 |
32 | outdating | 1 |
33 | parcels | 6 |
34 | phobics | 10 |
35 | postadsorber | 1 |
36 | pressure-a | 2 |
37 | pressure-by | 1 |
38 | pressure-guided | 7 |
39 | pressure-independent | 40 |
40 | pressure-insulin | 2 |
41 | pressure-lowering | 265 |
42 | pressure-loweringtherapies | 1 |
43 | pressure-reducing | 10 |
44 | pressure-regulating | 2 |
45 | pressure-related | 21 |
46 | pressure.further | 1 |
47 | pressure/diastolic | 16 |
48 | pressure/mean | 7 |
49 | pressurematched | 1 |
50 | pressures | 4,092 |
51 | pressures≥30mmhg | 1 |
52 | pressure≥140 | 2 |
53 | pressure≥90 | 1 |
54 | products/24 | 1 |
55 | proteins/steroids | 1 |
56 | prssure | 1 |
57 | pwvs | 12 |
58 | rheology | 105 |
59 | samples/dna | 1 |
60 | schizontocides | 1 |
61 | slides/month | 1 |
62 | smear-confirmed | 1 |
63 | stasis | 964 |
64 | stasis-dredging | 2 |
65 | stasis-heat | 5 |
66 | stasis-phlegm | 7 |
67 | stasis-type | 3 |
68 | stasis/stagnant | 1 |
69 | sugar-reducing | 1 |
70 | technology® | 1 |
71 | time/blood | 1 |
72 | time/rr | 2 |
73 | tinged | 3 |
74 | transfusion-and | 1 |
75 | transfusion/iron | 1 |
76 | velocity/end-diastolic | 1 |
77 | wave/em | 3 |
1 | pressure≥140 | 2 |
2 | pressure≥90 | 1 |
3 | products/24 | 1 |
4 | mdt-15 | 2 |
5 | cd16/56 | 2 |
6 | pressure-a | 2 |
7 | samples/dna | 1 |
8 | velocity/end-diastolic | 1 |
9 | pressure/diastolic | 16 |
10 | flow/systemic | 3 |
11 | pressure-guided | 7 |
12 | tinged | 3 |
13 | pressurematched | 1 |
14 | smear-confirmed | 1 |
15 | cell/red | 1 |
16 | cell-perfused | 5 |
17 | cell-transfused | 1 |
18 | pressure-related | 21 |
19 | circulation-related | 3 |
20 | institute-limited | 1 |
21 | cell-alloimmunized | 1 |
22 | convection-parameterized | 1 |
23 | transfusion-and | 1 |
24 | loss-and | 1 |
25 | time/blood | 1 |
26 | stasis-type | 3 |
27 | prssure | 1 |
28 | donors.we | 1 |
29 | pressures≥30mmhg | 1 |
30 | pressure-reducing | 10 |
31 | sugar-reducing | 1 |
32 | stasis-dredging | 2 |
33 | pressure-lowering | 265 |
34 | outdating | 1 |
35 | pressure-regulating | 2 |
36 | circulation-invigorating | 3 |
37 | slides/month | 1 |
38 | cell-neutrophil | 1 |
39 | wave/em | 3 |
40 | stasis-phlegm | 7 |
41 | flow/metabolism | 1 |
42 | pressure/mean | 7 |
43 | flow/mean | 1 |
44 | pressure-insulin | 2 |
45 | detoxification/purification | 1 |
46 | transfusion/iron | 1 |
47 | postadsorber | 1 |
48 | pressure.further | 1 |
49 | time/rr | 2 |
50 | phobics | 10 |
51 | proteins/steroids | 1 |
52 | schizontocides | 1 |
53 | pressure-loweringtherapies | 1 |
54 | pressures | 4,092 |
55 | gases | 743 |
56 | gasses | 11 |
57 | karyocytes | 1 |
58 | drags | 3 |
59 | nondippings | 1 |
60 | mvgs | 1 |
61 | stasis | 964 |
62 | parcels | 6 |
63 | bankers | 2 |
64 | clots | 131 |
65 | pwvs | 12 |
66 | airflows | 15 |
67 | stasis-heat | 5 |
68 | stasis/stagnant | 1 |
69 | pressure-independent | 40 |
70 | leukocytes.clinicaltrials.gov | 1 |
71 | bmc/bw | 2 |
72 | middle/low | 1 |
73 | pressure-by | 1 |
74 | rheology | 105 |
75 | leucocyte-mainly | 1 |
76 | incoagulability | 1 |
77 | technology® | 1 |